140 related articles for article (PubMed ID: 20804047)
1. [Predictors and prognostic models in childhood and adolescent Hodgkin's disease].
Kuleva SA; Kolygin BA
Vopr Onkol; 2010; 56(3):272-7. PubMed ID: 20804047
[No Abstract] [Full Text] [Related]
2. Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
Constine LS; Wolkov HB; Yahalom J; Mauch PM; Deming RL; Dosoretz DE; Elman AJ; Hoppe RT; Pistenmaa DA; Prosnitz LR; Chauvenet A; Connors JM; Glick JH; Leibel S
Radiology; 2000 Jun; 215 Suppl():1225-56. PubMed ID: 11037544
[No Abstract] [Full Text] [Related]
3. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
5. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
[TBL] [Abstract][Full Text] [Related]
6. A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease.
Hahn T; Benekli M; Wong C; Moysich KB; Hyland A; Michalek AM; Alam A; Baer MR; Bambach B; Czuczman MS; Wetzler M; Becker JL; McCarthy PL
Bone Marrow Transplant; 2005 Mar; 35(6):557-66. PubMed ID: 15665852
[TBL] [Abstract][Full Text] [Related]
7. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
[TBL] [Abstract][Full Text] [Related]
8. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Group d'Etudes des Lymphomes de l'Adulte Study.
Fermé C; Bastion Y; Brice P; Lederlin P; Diviné M; Gabarre J; Assouline D; Ferrant A; Berger F; Lepage E
Cancer; 1997 Sep; 80(6):1124-33. PubMed ID: 9305714
[TBL] [Abstract][Full Text] [Related]
10. The topoisomerase IIalpha expression correlates with survival in patients with advanced Hodgkin's lymphoma.
Provencio M; Corbacho C; Salas C; Millan I; Espana P; Bonilla F; Ramon Cajal S
Clin Cancer Res; 2003 Apr; 9(4):1406-11. PubMed ID: 12684412
[TBL] [Abstract][Full Text] [Related]
11. Verification and comparison of two different predictive equations in Hodgkin's disease.
Bettini R; Tonolini M; Maccianti E
Haematologica; 1997; 82(3):324-7. PubMed ID: 9234580
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of the histologic type of Hodgkin's disease as a prognostic factor].
Shust VF; Markochev AB; Skripkina NS
Vopr Onkol; 1989; 35(10):1251-4. PubMed ID: 2596072
[TBL] [Abstract][Full Text] [Related]
13. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
[TBL] [Abstract][Full Text] [Related]
14. [Outcomes prediction for children with Hodgkin's disease].
Kolygin BA; Anishkin MIu
Vopr Onkol; 2006; 52(3):322-5. PubMed ID: 17191706
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.
Gallamini A; Rigacci L; Merli F; Nassi L; Bosi A; Capodanno I; Luminari S; Vitolo U; Sancetta R; Iannitto E; Trentin L; Stelitano C; Tavera S; Biggi A; Castagnoli A; Versari A; Gregianin M; Pelosi E; Torchio P; Levis A
Haematologica; 2006 Apr; 91(4):475-81. PubMed ID: 16585014
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
Fleury J; Tortochaux J; Legros M; Cure H; Kwiatkowski F; Ferrière JP; Travade P; Dionet C; Gaillard G; Chassagne J
Bull Cancer; 1994 Jul; 81(7):625-31. PubMed ID: 7742606
[TBL] [Abstract][Full Text] [Related]
17. High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience.
Sperotto A; Zaja F; Damiani D; Patriarca F; Fanin R
Haematologica; 2001 Dec; 86(12):1317-8. PubMed ID: 11726327
[No Abstract] [Full Text] [Related]
18. Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution.
Smolewski P; Robak T; Krykowski E; Blasiñska-Morawiec M; Niewiadomska H; Pluzanska A; Chmielowska E; Zambrano O
Clin Cancer Res; 2000 Mar; 6(3):1150-60. PubMed ID: 10741746
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in advanced Hodgkin's disease--can they guide therapeutic decisions?
Brice P
N Engl J Med; 1998 Nov; 339(21):1547-9. PubMed ID: 9819456
[No Abstract] [Full Text] [Related]
[Next] [New Search]